These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 6575729)
1. [Administration of aclarubicin in malignant lymphoma]. Takagi T; Oguro M; Iwabuchi K Gan To Kagaku Ryoho; 1983 Jun; 10(6):1540-1. PubMed ID: 6575729 [No Abstract] [Full Text] [Related]
2. Clinical evaluation of a new anthracycline antibiotic, aclacinomycin-A, in patients with advanced malignant lymphoma. Warrell RP; Kempin SJ Am J Clin Oncol; 1983 Feb; 6(1):81-4. PubMed ID: 6573124 [No Abstract] [Full Text] [Related]
3. [Aclacinomycin-A in acute leukaemias and leukaemic non-Hodgkin lymphomas (author's transl)]. Mathé G; de Jager R; Hulhoven R; Delgado M; Machover D; Ribaud P; de Vassal F; Gil-Delgado M; Misset JL; Gouveia J; Jasmin C; Hayat M; Gastiaburu J; Schwarzenberg L Nouv Presse Med; 1982 Jan; 11(1):25-8. PubMed ID: 6949137 [TBL] [Abstract][Full Text] [Related]
4. [Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia]. Takahashi I; Hara M; Ohmoto E; Oda Y; Endo Y; Fujimoto S; Uchida K; Takaoka K; Watanabe S; Lai M; Kohi F; Kitajima K; Kimura I; Sanada H; Tokioka M; Adachi T; Yorimitsu S Gan To Kagaku Ryoho; 1982 Sep; 9(9):1617-22. PubMed ID: 6964050 [TBL] [Abstract][Full Text] [Related]
5. [New agents in the treatment of leukemia and lymphoma]. Yamada K Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1031-40. PubMed ID: 6347079 [No Abstract] [Full Text] [Related]
6. [Intravesical instillation therapy of aclacinomycin-A (ACM) for superficial bladder tumor]. Noguchi S; Kubota Y; Shuin T; Miura T; Moriyama M; Sakuramoto T; Oshima H Hinyokika Kiyo; 1984 Sep; 30(9):1153-8. PubMed ID: 6596878 [TBL] [Abstract][Full Text] [Related]
7. Phase I-II study of aclarubicin for treatment of acute myeloid leukemia. Machover D; Gastiaburu J; Delgado M; Goldschmidt E; Hulhoven R; Misset JL; de Vassal F; Tapiero H; Ribaud P; Schwarzenberg L Cancer Treat Rep; 1984 Jun; 68(6):881-6. PubMed ID: 6587933 [TBL] [Abstract][Full Text] [Related]
8. Clinical phase I study of aclacinomycin A by evaluation of an intermittent intravenous administration schedule. Casper ES; Gralla RJ; Young CW Cancer Res; 1981 Jun; 41(6):2417-20. PubMed ID: 6940656 [TBL] [Abstract][Full Text] [Related]
9. [Evaluation of aclacinomycin-A in head and neck cancer]. Tsukuda M Gan To Kagaku Ryoho; 1984 Nov; 11(11):2335-41. PubMed ID: 6594077 [TBL] [Abstract][Full Text] [Related]
10. [Effects of single administration of tetrahydropyranyladriamycin (THP) in lymphoid malignancy]. Takagi T; Oguro M; Iwabuchi K Gan To Kagaku Ryoho; 1984 Jul; 11(7):1450-6. PubMed ID: 6588924 [TBL] [Abstract][Full Text] [Related]
11. Experimental and clinical studies on aclarubicin in the treatment of solid tumors. Kumai K; Kubota T; Ishibiki K; Abe O Biomed Pharmacother; 1984; 38(7):332-7. PubMed ID: 6596963 [TBL] [Abstract][Full Text] [Related]
12. Anthracyclines in the treatment of acute nonlymphocytic leukemias. Boiron M; Jacquillat C; Marty M; Weil M; Gisselbrecht C Cancer Treat Rep; 1981; 65 Suppl 4():73-6. PubMed ID: 6955013 [No Abstract] [Full Text] [Related]
13. [Optimal administration schedules of antineoplastic antibiotics based on their pharmacokinetics, with special reference to bleomycins and anthracyclines]. Ota K; Goto T; Fukushima M; Ariyoshi Y Gan To Kagaku Ryoho; 1982 Aug; 9(8):1352-61. PubMed ID: 6191712 [TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy with aclarubicin in metastatic breast cancer. Simader H; Hausmaninger H; Fereberger W; Samonigg H Eur J Haematol Suppl; 1987; 47():71-6. PubMed ID: 3471528 [No Abstract] [Full Text] [Related]
15. Aclarubicin in single agent and combined chemotherapy of acute myeloid leukaemias. Mitrou PS Eur J Haematol Suppl; 1987; 47():59-66. PubMed ID: 3471526 [No Abstract] [Full Text] [Related]
16. [Pharmacokinetic study of aclarubicin. The pharmacokinetics of the preparation and its biologically active metabolites in the blood of rats]. Geodakian SV; Firsov AA; Fomina IP Antibiot Med Biotekhnol; 1987 Oct; 32(10):768-72. PubMed ID: 3480699 [TBL] [Abstract][Full Text] [Related]
17. [Studies on hematological diseases in elderly patients. Part 4: Chemotherapeutic effect of aclarubicin (ACR) on acute nonlymphocytic leukemia in the aged]. Yorimitsu S; Takahashi I; Lai M; Ohmoto E; Aoyama S; Inagaki T; Ueda I; Nishimura M; Nakada H; Nonaka K Nihon Ronen Igakkai Zasshi; 1986 May; 23(3):302-8. PubMed ID: 3463814 [No Abstract] [Full Text] [Related]
18. [Pharmacokinetic study of aclarubicin. The distribution of the preparation and its biologically active metabolites in rat tissues]. Firsov AA; Geodakian SV; Egorov LV; Terent'eva TG Antibiot Med Biotekhnol; 1987 Oct; 32(10):773-7. PubMed ID: 3480700 [TBL] [Abstract][Full Text] [Related]
20. Phase II evaluation of aclarubicin in refractory multiple myeloma: a Southeastern Cancer Study Group Trial. Gockerman JP; Silberman H; Bartolucci AA Cancer Treat Rep; 1987; 71(7-8):773-4. PubMed ID: 3300970 [No Abstract] [Full Text] [Related] [Next] [New Search]